NDA 18321, held by Curium. Technetium Tc-99m Oxidronate Kit.
As of Nov 14, 2026, NDA 18321 (Technescan Hdp), held by Curium, was first approved by FDA on Feb 18, 1981, with 13 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Technescan HDP, after radiolabeling with sodium pertechnetate Tc 99m, is indicated for skeletal imaging to demonstrate areas of altered osteogenesis in adult and pediatric patients.
| Apr 28, 1989 | Supplement 8Efficacy (new indication or use) | Approved | None posted |
| Feb 18, 1981 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Technescan HdpN/A · injectable;injection | Technetium Tc-99m Oxidronate Kit | RxReference drug |
| Nov 24, 2025 | Supplement 25Labeling · Standard review | Approved | |
| May 22, 2025 | Supplement 26Labeling · Standard review | Approved | |
| Mar 31, 2017 | Supplement 22Labeling · Standard review | Approved | |
| Jun 17, 2014 | Supplement 21Manufacturing · Standard review | Approved | None posted |
| Mar 14, 2013 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Apr 8, 1998 | Supplement 16Manufacturing · Standard review | Approved | None posted |
| Feb 29, 1996 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| Jul 14, 1994 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 28, 1989 | Supplement 8Efficacy (new indication or use) | Approved | None posted |
| Sep 30, 1988 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| Nov 5, 1987 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Jan 10, 1986 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Feb 3, 1983 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Feb 18, 1981 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters